# Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

> **NCT01156012** · PHASE3 · COMPLETED · sponsor: **Laboratoires Thea** · enrollment: 404 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** T2345
- **DRUG:** Prostaglandin

## Key facts

- **NCT ID:** NCT01156012
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2015-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156012, "Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01156012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*